TR200100948T2 - Cinsel yoldan bulaşan hastalıklara karşı aşı - Google Patents

Cinsel yoldan bulaşan hastalıklara karşı aşı

Info

Publication number
TR200100948T2
TR200100948T2 TR200100948T TR200100948T TR200100948T2 TR 200100948 T2 TR200100948 T2 TR 200100948T2 TR 200100948 T TR200100948 T TR 200100948T TR 200100948 T TR200100948 T TR 200100948T TR 200100948 T2 TR200100948 T2 TR 200100948T2
Authority
TR
Turkey
Prior art keywords
sexually transmitted
transmitted diseases
vaccine against
prevent
treat
Prior art date
Application number
TR200100948T
Other languages
English (en)
Inventor
Mohamed Slaoui Moncef
G. Vandepapeliere Pierre
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200100948(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of TR200100948T2 publication Critical patent/TR200100948T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Cinsel yoldan bulasan hastaliklara neden olan patojenler ile iliskili enfeksiyonlari önlemek ya da tedavi etmek için, kadinlara bir asinin tatbik edilme yöntemi tarif edilir. Asi, cinsel yoldan bulasan hastaliklarin önlenmesi ya da tedavi edilmesi için bir ya da daha fazla antijeni, örnegin; HSV glikoprotein D ya da bunun immünolojik bir parçasi ve bir adjuvani, özellikle de bir TH-1 indükleyici adjuvani kapsar. Kadinlarda cinsel yoldan bulasan hastaliklarin önlenmesi ya da tedavi edilmesi için, bir asi bilesiminin formülasyonu için asi bilesenlerinin kullanilmasi da tarif edilmektedir.
TR200100948T 1998-09-11 1999-09-08 Cinsel yoldan bulaşan hastalıklara karşı aşı TR200100948T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9819898A GB9819898D0 (en) 1998-09-11 1998-09-11 New vaccine and method of use

Publications (1)

Publication Number Publication Date
TR200100948T2 true TR200100948T2 (tr) 2001-07-23

Family

ID=10838766

Family Applications (1)

Application Number Title Priority Date Filing Date
TR200100948T TR200100948T2 (tr) 1998-09-11 1999-09-08 Cinsel yoldan bulaşan hastalıklara karşı aşı

Country Status (28)

Country Link
EP (1) EP1109574B1 (tr)
JP (1) JP2002524532A (tr)
KR (1) KR100777896B1 (tr)
CN (2) CN101130070A (tr)
AR (1) AR021798A1 (tr)
AT (1) ATE392214T1 (tr)
AU (1) AU744989B2 (tr)
BR (1) BR9913630A (tr)
CA (1) CA2343399C (tr)
CO (1) CO5090882A1 (tr)
CY (1) CY1108147T1 (tr)
CZ (1) CZ302808B6 (tr)
DE (1) DE69938555T2 (tr)
DK (1) DK1109574T3 (tr)
ES (1) ES2304068T3 (tr)
GB (1) GB9819898D0 (tr)
HU (1) HUP0104297A3 (tr)
IL (1) IL141843A0 (tr)
MY (1) MY122216A (tr)
NO (1) NO329522B1 (tr)
NZ (1) NZ510425A (tr)
PL (1) PL199545B1 (tr)
PT (1) PT1109574E (tr)
SI (1) SI1109574T1 (tr)
TR (1) TR200100948T2 (tr)
TW (1) TWI225790B (tr)
WO (1) WO2000015255A1 (tr)
ZA (1) ZA200101987B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2284287T3 (es) 1998-10-16 2007-11-01 Glaxosmithkline Biologicals S.A. Sistemas adyuvantes y vacunas.
GB9921146D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
WO2007081447A2 (en) 2005-11-22 2007-07-19 Novartis Vaccines And Diagnostics, Inc. Norovirus and sapovirus antigens
AU2007281934B2 (en) 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
US8287885B2 (en) 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
EP2443250B8 (en) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
EP3730943B1 (en) 2010-04-08 2025-01-29 University of Pittsburgh - Of the Commonwealth System of Higher Education B-cell antigen presenting cell assay
CN102933267B (zh) 2010-05-28 2015-05-27 泰特里斯在线公司 交互式混合异步计算机游戏基础结构
EP2726097A4 (en) 2011-07-01 2015-03-11 Univ California HERPES VIRUS VACCINE AND METHOD OF USE
BR112017000285A2 (pt) 2014-07-07 2017-10-31 Prophylaxis LLC métodos de tratamento da profilaxia viral e kits de profilaxia de pré-exposição
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
WO2017144359A1 (en) 2016-02-22 2017-08-31 Boehringer Ingelheim Vetmedica Gmbh Method for the immobilization of biomolecules
WO2020086408A1 (en) 2018-10-26 2020-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A high-yield perfusion-based transient gene expression bioprocess

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
KR100310510B1 (ko) * 1993-03-23 2002-07-04 장 스테판느 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
AU5975299A (en) 2000-04-03
NO20011193L (no) 2001-05-09
DK1109574T3 (da) 2008-06-30
DE69938555T2 (de) 2009-06-10
HUP0104297A3 (en) 2004-10-28
ZA200101987B (en) 2002-05-09
ES2304068T3 (es) 2008-09-01
CN101130070A (zh) 2008-02-27
CY1108147T1 (el) 2014-02-12
DE69938555D1 (de) 2008-05-29
AR021798A1 (es) 2002-08-07
MY122216A (en) 2006-03-31
KR100777896B1 (ko) 2007-11-27
PL346651A1 (en) 2002-02-25
KR20010075049A (ko) 2001-08-09
CZ2001887A3 (cs) 2001-10-17
CZ302808B6 (cs) 2011-11-23
NZ510425A (en) 2003-04-29
JP2002524532A (ja) 2002-08-06
CA2343399C (en) 2010-08-03
EP1109574B1 (en) 2008-04-16
AU744989B2 (en) 2002-03-07
PT1109574E (pt) 2008-06-12
HK1037978A1 (en) 2002-03-01
SI1109574T1 (sl) 2008-08-31
TWI225790B (en) 2005-01-01
GB9819898D0 (en) 1998-11-04
CO5090882A1 (es) 2001-10-30
IL141843A0 (en) 2002-03-10
ATE392214T1 (de) 2008-05-15
NO20011193D0 (no) 2001-03-08
WO2000015255A1 (en) 2000-03-23
NO329522B1 (no) 2010-11-01
HUP0104297A2 (hu) 2002-03-28
CA2343399A1 (en) 2000-03-23
BR9913630A (pt) 2001-05-22
CN1325311A (zh) 2001-12-05
EP1109574A1 (en) 2001-06-27
PL199545B1 (pl) 2008-09-30

Similar Documents

Publication Publication Date Title
CY1108147T1 (el) Εμβολιο κατα των σεξουαλικως μεταδιδομενων νοσων
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
ATE262348T1 (de) Mittel zur verabreichung von antigenen
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
BR9814487A (pt) "vacina"
YU28392A (sh) Vakcina koja sadrži glikoprotein d i 3deacilovani monofosforil lipid a
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
MA28149A1 (fr) Compositions de vaccin comprenant une interleukine 18 et un systeme adjuvant de type saponine
DE69425427D1 (de) Ein pharmazeutisches präparat zur topischen verabreichung von antigenen und/oder vakzinen an die schleimhäute von säugern
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
BR9814473A (pt) Imunógenos anti-retrovirais, preparação e uso
NZ337885A (en) vaccine formulation of an antigen, a TH-1 inducing adjuvant and a sparingly water soluble amino acid
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
KR960700746A (ko) 헬리코박터 피롤리 관련 위십이지장 질환의 치료 방법(treatment of h. pylori associated gastroduodenal disease)
EP0954529A4 (en) Porphyromonas gingivalis antigen for the diagnosis and treatment of periodontitis
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
ES2096988T3 (es) Organopolisiloxanos que contienen grupos hidrofilos.
NZ507829A (en) Vaccine adjuvants for immunotherapy of melanoma
EP0955366A4 (en) ANTIGENIC PROTEIN FROM MALASSEZIA
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
HUP9901299A2 (hu) Attenuált, nemimmunogén poxvírusokból vagy parapoxvírusokból előállított multipotens parapox immunitást előidéző gyógyszerek használatának új indikációi
FR2735984B1 (fr) Vaccin contre des agents infectieux ayant une phase intracellulaire, composition pour le traitement et la prevention des infections a hiv, anticorps et procede de diagnostic